Steris (NYSE:STE) reported quarterly earnings of $1.90 per share which missed the analyst consensus estimate of $1.91 by 0.52 percent. This is a 7.95 percent increase over earnings of $1.76 per share from the same period last year.
ZyVersa Therapeutics, Inc. Announces Pricing Of $2.1M Public Offering Of 12,727,273 Shares Of Common Stock And Warrants At A Price Of $0.165/Unit
ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA, or ", ZyVersa", or ", the Company", )))), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory
